US FDA

21 CFR Part 211 Module 3: Components & Containers

Subpart E requirements for receiving, testing, approving and retesting components, and for drug product containers and closures.

What this course covers

This module covers Subpart E in full: general requirements for component receipt under 211.80, testing and approval or rejection of components under 211.84, retesting requirements for approved components, containers and closures under 211.87, and the requirements specific to drug product containers and closures under 211.94.

Who this course is for

What you'll learn

Why it matters

Component control is where a quality problem often first enters a facility, before it ever reaches production. A gap here, an untested lot released to the floor, an expired retest interval, propagates into every batch that uses that component.

Related

Included in the full GMPify subscription

Completion certificate, PDF slide download, and access to the complete GMP course library from day one.

Start this course →